HK1211594A1 - Human relaxin analogue, pharmaceutical composition of same, and pharmaceutical application of same - Google Patents

Human relaxin analogue, pharmaceutical composition of same, and pharmaceutical application of same

Info

Publication number
HK1211594A1
HK1211594A1 HK15112223.7A HK15112223A HK1211594A1 HK 1211594 A1 HK1211594 A1 HK 1211594A1 HK 15112223 A HK15112223 A HK 15112223A HK 1211594 A1 HK1211594 A1 HK 1211594A1
Authority
HK
Hong Kong
Prior art keywords
same
pharmaceutical
human relaxin
pharmaceutical composition
application
Prior art date
Application number
HK15112223.7A
Other languages
English (en)
Chinese (zh)
Inventor
張連山
劉佳建
曹國慶
Original Assignee
Shanghai Hengrui Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Hengrui Pharm Co Ltd filed Critical Shanghai Hengrui Pharm Co Ltd
Publication of HK1211594A1 publication Critical patent/HK1211594A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK15112223.7A 2013-11-07 2015-12-11 Human relaxin analogue, pharmaceutical composition of same, and pharmaceutical application of same HK1211594A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201310548221 2013-11-07
PCT/CN2014/088280 WO2015067113A1 (zh) 2013-11-07 2014-10-10 人松驰素类似物、其药物组合物及其在医药上的应用

Publications (1)

Publication Number Publication Date
HK1211594A1 true HK1211594A1 (en) 2016-05-27

Family

ID=53040882

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112223.7A HK1211594A1 (en) 2013-11-07 2015-12-11 Human relaxin analogue, pharmaceutical composition of same, and pharmaceutical application of same

Country Status (13)

Country Link
US (1) US20160326230A1 (ru)
EP (1) EP3067365A1 (ru)
JP (1) JP2016536306A (ru)
KR (1) KR20160071472A (ru)
CN (1) CN104870470B (ru)
AU (1) AU2014346141A1 (ru)
BR (1) BR112016009572A2 (ru)
CA (1) CA2928754A1 (ru)
HK (1) HK1211594A1 (ru)
MX (1) MX2016005545A (ru)
RU (1) RU2016117959A (ru)
TW (1) TW201518319A (ru)
WO (1) WO2015067113A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107007822A (zh) * 2016-01-27 2017-08-04 江苏恒瑞医药股份有限公司 一种含有重组人松弛素‑2类似物的药物组合物及其制备方法
CN107417787B (zh) * 2016-05-23 2020-11-17 江苏恒瑞医药股份有限公司 一种人松弛素2类似物的制备方法
SG11201907209QA (en) * 2017-02-08 2019-09-27 Bristol Myers Squibb Co Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
TWI844709B (zh) * 2019-07-31 2024-06-11 美商美國禮來大藥廠 鬆弛素(relaxin)類似物及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
EP1729817B1 (en) * 2004-03-30 2014-03-05 Industry-Academic Cooperation Foundation Gene delivery system containing relaxin gene and pharmaceutical composition using relaxin
MX2010012502A (es) * 2008-05-16 2011-04-11 Corthera Inc Metodo para el tratamiento de insuficiencia cardiaca cronica.
CN102180964B (zh) * 2011-03-16 2013-06-05 济南环肽医药科技有限公司 一种人类松弛素-2 Relaxin的固相合成方法
CN102603888B (zh) * 2012-04-11 2013-11-20 黑龙江八一农垦大学 一种人松弛素2前体及其制备方法

Also Published As

Publication number Publication date
CN104870470A (zh) 2015-08-26
CA2928754A1 (en) 2015-05-14
EP3067365A1 (en) 2016-09-14
RU2016117959A (ru) 2017-12-11
CN104870470B (zh) 2017-10-10
WO2015067113A1 (zh) 2015-05-14
MX2016005545A (es) 2016-10-03
KR20160071472A (ko) 2016-06-21
US20160326230A1 (en) 2016-11-10
TW201518319A (zh) 2015-05-16
AU2014346141A1 (en) 2016-05-19
BR112016009572A2 (pt) 2017-09-19
JP2016536306A (ja) 2016-11-24

Similar Documents

Publication Publication Date Title
HK1251153A1 (zh) 一種藥物組合物及其應用
HK1220980A1 (zh) 用於治療龐貝氏症的方法和組合物
IL240519B (en) History 1)]-n-heteroaryl-2-phenyl)ethyl]-(heterocyclyl-acetamide) and pharmaceutical preparations containing them
IL240290A0 (en) History of pyridazinone-amide and pharmaceutical preparations containing them
IL243608A0 (en) Substances with antiviral activity, preparations containing them and their uses
EP2981611A4 (en) ANTIBIOTICUM PROTOCOLS AND PHARMACEUTICAL FORMULATIONS AND TREATMENT METHODS THEREWITH
EP2815746A4 (en) SAPONIN NANOMIZELES, MANUFACTURING METHOD, APPLICATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREOF
HK1221416A1 (zh) 氧雜雙環庚烷和氧雜雙環庚烯的配製品
HK1220920A1 (zh) 治療性組合物和其用途
HK1222563A1 (zh) 藥物組合物、製備及其用途
HK1215859A1 (zh) 包含蜂膠提取物的治療性組合物和其用途
HK1218079A1 (zh) 亞硝酸鹽的藥物製劑及其用途
EP2995308A4 (en) ANTI-HYPOXIC PHARMACEUTICAL COMPOSITION AND USE THEREOF
HK1219691A1 (zh) 醫藥組成物及其用途
IL243227A0 (en) History of diaminocyclopentane carboxamide, their preparation and pharmaceutical preparations containing them
SI3228313T1 (sl) Odmerne oblike in terapevtske uporabe L-4-klorokinurenina
HK1211594A1 (en) Human relaxin analogue, pharmaceutical composition of same, and pharmaceutical application of same
IL240292B (en) History of quinazoline and pharmaceutical preparations containing them
IL245015A0 (en) Medicinal composition containing icotinib for topical treatment of the skin and its use
EP3078659A4 (en) 3-FURYL-2-CYANO-2-ACRYLAMIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION AND USE THEREOF
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
HK1217670A1 (zh) 調配物、其製造方法和用途
IL284405A (en) Pharmaceutical composition, preparation and uses thereof
TH1401007694A (th) องค์ประกอบทางเภสัชกรรมและการรักษาเต้านมอักเสบ (pharmaceutical compositions and treatment of mastitis)